Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald A Berry

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
Biometrics|August 11, 2007
A parallel phase I/II clinical trial design for combination therapiesXuelin Huang, Swati Biswas, Yasuhiro Oki, et al.
Medical Care|May 18, 2010
Bayesian meta-analyses for comparative effectiveness and informing coverage decisionsScott M Berry, K Jack Ishak, Bryan R Luce, et al.
Archives of Internal Medicine|June 15, 2011
FDA recalls not as alarming as they seemJason T Connor, Roger J Lewis, Donald A Berry, et al.
Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.
JAMA|November 8, 2007
Limited family structure and breast cancer riskEdwin S Iversen, Hormuzd A Katki, Sining Chen, et al.
Clinical Trials (London, England)|August 22, 2022
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trialsBenjamin R Saville, Donald A Berry, Nicholas S Berry, et al.
Genetics|October 7, 2004
Using molecular sizes of simple sequence repeats vs. discrete binned data in assessing probability of ancestry: application to maize hybridsDonald A Berry, Deanne Wright, Chongqing Xie, et al.
Statistics in Medicine|March 28, 2009
Using short-term response information to facilitate adaptive randomization for survival clinical trialsXuelin Huang, Jing Ning, Yisheng Li, et al.
Epidemiologic Reviews|December 31, 2013
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusMark F Munsell, Brian L Sprague, Donald A Berry, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
An informatics tool to assess colon cancer riskConstance Johnson, Joe Ensor, Christopher Amos, et al.
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Biometrics|August 11, 2007
A parallel phase I/II clinical trial design for combination therapiesXuelin Huang, Swati Biswas, Yasuhiro Oki, et al.
Medical Care|May 18, 2010
Bayesian meta-analyses for comparative effectiveness and informing coverage decisionsScott M Berry, K Jack Ishak, Bryan R Luce, et al.
Archives of Internal Medicine|June 15, 2011
FDA recalls not as alarming as they seemJason T Connor, Roger J Lewis, Donald A Berry, et al.
Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.
JAMA|November 8, 2007
Limited family structure and breast cancer riskEdwin S Iversen, Hormuzd A Katki, Sining Chen, et al.
Clinical Trials (London, England)|August 22, 2022
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trialsBenjamin R Saville, Donald A Berry, Nicholas S Berry, et al.
Genetics|October 7, 2004
Using molecular sizes of simple sequence repeats vs. discrete binned data in assessing probability of ancestry: application to maize hybridsDonald A Berry, Deanne Wright, Chongqing Xie, et al.
Statistics in Medicine|March 28, 2009
Using short-term response information to facilitate adaptive randomization for survival clinical trialsXuelin Huang, Jing Ning, Yisheng Li, et al.
Epidemiologic Reviews|December 31, 2013
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusMark F Munsell, Brian L Sprague, Donald A Berry, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
An informatics tool to assess colon cancer riskConstance Johnson, Joe Ensor, Christopher Amos, et al.
Pageof 20